Versant Venture Capital III, L.P., 10% Owner at Trius Therapeutics Inc (TSRX), bought 3,235,839 shares at $5.00 ($7.8M) on 2010-08-06, disclosed to the SEC on 2010-08-10.
Open-market purchase of $7.8M TSRX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,576,814 | $0 | 0.0% |
| 2 | $4.38 | 744,496 | $3.3M | 41.6% |
| 3 | $5.00 | 914,529 | $4.6M | 58.4% |
| Total | $2.42 avg | 3,235,839 | $7.8M | 100% |
| Filing → |
| FLXN | BUY | 2014-02-20 | $4.0M | — | Filing → |